| Schedule of significant expense categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Operating Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
PMN310 development program costs |
|
$ |
8,050,610 |
|
$ |
1,073,864 |
|
$ |
12,776,951 |
|
$ |
2,623,174 |
|
Other non-employee research and development costs |
|
|
220,669 |
|
|
194,620 |
|
|
498,584 |
|
|
418,972 |
|
Employee costs |
|
|
1,053,258 |
|
|
536,021 |
|
|
2,496,325 |
|
|
1,117,031 |
|
Other general and administrative costs |
|
|
860,124 |
|
|
909,201 |
|
|
1,872,897 |
|
|
2,231,180 |
|
Net Operating Loss: |
|
|
10,184,661 |
|
|
2,713,706 |
|
$ |
17,644,757 |
|
$ |
6,390,357 |
|
Other segment items(a) |
|
|
(67,632) |
|
|
(90,049) |
|
|
(179,825) |
|
|
(131,612) |
|
Net Loss: |
|
|
10,117,029 |
|
|
2,623,657 |
|
$ |
17,464,932 |
|
$ |
6,258,745 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of profit or loss |
|
$ |
|
|
$ |
|
|
|
|
|
|
|
|
Adjustments and reconciling items |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Consolidated net loss: |
|
|
10,117,029 |
|
|
2,623,657 |
|
$ |
17,464,932 |
|
$ |
6,258,745 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)Other segment items included in segment loss include changes in warrant liability, interest income, and interest expense |
|